Literature DB >> 17727824

Systematic review: pharmacological and behavioral treatment for trichotillomania.

Michael H Bloch1, Angeli Landeros-Weisenberger, Philip Dombrowski, Ben Kelmendi, Ryan Wegner, Jake Nudel, Christopher Pittenger, James F Leckman, Vladimir Coric.   

Abstract

Trichotillomania is a psychiatric condition characterized by compulsive hair pulling. Three interventions have been studied in the treatment of trichotillomania: habit-reversal therapy (HRT) and pharmacotherapy with either selective-serotonin reuptake inhibitors (SSRI) or clomipramine. This systematic review compared the efficacy of these interventions in blinded, randomized clinical trials. The electronic databases of Medline, Premedline, PsychINFO, Embase, and the Cochrane Central Register of Controlled Trials were searched for relevant trials using the search terms "trichotillomania" or "hair pulling." Trials were eligible for inclusion if they compared habit-reversal therapy, SSRI pharmacotherapy, or clomipramine pharmacotherapy to each other or placebo and employed randomization and blinded assessment of outcome. Our primary outcome measure was mean change in trichotillomania severity. The summary statistic was standardized mean difference. Seven studies were eligible for inclusion in this review. Overall, meta-analysis demonstrated that habit-reversal therapy (effect size [ES] = -1.14, 95% confidence interval [CI] = -1.89, -.38) was superior to pharmacotherapy with clomipramine (ES = -.68, 95% CI = -1.28, -.07) or SSRI (ES = .02, 95% CI = -.32, .35). Clomipramine was more efficacious than placebo, while there was no evidence to demonstrate that SSRI are more efficacious than placebo in the treatment of trichotillomania. Future studies on trichotillomania should seek to determine if HRT can demonstrate efficacy against more rigorous control conditions that account for non-specific effects of therapy and determine if HRT can be an effective intervention for trichotillomania beyond the few sites where it is currently practiced in research studies. Future therapy and pharmacotherapy studies in trichotillomania should employ larger sample sizes and intention-to-treat analysis and seek to validate clinical rating scales of trichotillomania severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727824     DOI: 10.1016/j.biopsych.2007.05.019

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  45 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 2.  Diagnosis, evaluation, and management of trichotillomania.

Authors:  Douglas W Woods; David C Houghton
Journal:  Psychiatr Clin North Am       Date:  2014-07-21

3.  A patch of hair loss on the scalp.

Authors:  Jason Emer; Adam Luber; Jaime Gropper; Harleen Sidhu; Robert Phelps
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

Review 4.  [Psychosomatic disorders of the scalp].

Authors:  W Harth
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

5.  Race/Ethnicity and Treatment Outcome in a Randomized Controlled Trial for Trichotillomania (Hair-Pulling Disorder).

Authors:  Martha J Falkenstein; Kate Rogers; Elizabeth J Malloy; David A F Haaga
Journal:  J Clin Psychol       Date:  2015-04-01

6.  Factor analysis of the Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version.

Authors:  Jennifer R Alexander; David C Houghton; Michael P Twohig; Martin E Franklin; Stephen M Saunders; Angela M Neal-Barnett; Scott N Compton; Douglas W Woods
Journal:  J Obsessive Compuls Relat Disord       Date:  2016-08-16       Impact factor: 1.677

7.  Age and gender correlates of pulling in pediatric trichotillomania.

Authors:  Kaitlyn E Panza; Christopher Pittenger; Michael H Bloch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-03       Impact factor: 8.829

8.  N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial.

Authors:  Michael H Bloch; Kaitlyn E Panza; Jon E Grant; Christopher Pittenger; James F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-03       Impact factor: 8.829

9.  Recent Advances in the Understanding and Treatment of Trichotillomania.

Authors:  Michael R Walther; Emily J Ricketts; Christine A Conelea; Douglas W Woods
Journal:  J Cogn Psychother       Date:  2010-02-01

10.  Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.

Authors:  Michael H Bloch; Kaitlyn E Panza; Angeli Landeros-Weisenberger; James F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-09       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.